Are elevated eosinophils and basophils markers of type 2 (Th2) allergic inflammation driven by ongoing allergen exposure and histamine activation?

Type 2 (Th2) allergic inflammation is a highly coordinated immune response driven by environmental exposures and maintained by complex cellular signaling. The assessment of whether elevated eosinophils and basophils serve as markers for this pathway, driven by ongoing allergen exposure and histamine-mediated activation, is supported by strong scientific evidence.

Clinical and mechanistic evidence

The biological pathways linking environmental exposures, helper T cells, and downstream granulocyte activation are well-established:

• Allergen-driven polarization: Ongoing exposure and sensitization to allergens or irritants activate dendritic cells, which prime naive CD4+ T cells to polarize into helper T2 (Th2) cells. This process initiates type 2 inflammation, characterized by the signature cytokines interleukin-4 (IL-4), IL-5, and IL-13.
• Granulocyte recruitment as biomarkers:
  • Eosinophils: IL-5 drives the differentiation, bone marrow release, and survival of eosinophils. Consequently, blood eosinophilia is a highly reliable, clinically established biomarker for active type 2 inflammation.
  • Basophils: Basophils accumulate in inflamed tissues during active atopic conditions. They act as key effector cells and regulatory gatekeepers, facilitating and regulating the tissue entry of eosinophils.
• Histamine-mediated amplification: Histamine, released primarily by basophils and mast cells, actively recruits effector cells to target tissues. Specifically, histamine acts via Gi-coupled histamine H4 receptors (H4R) to induce rapid cell shape changes, upregulate adhesion molecules, and directly promote the chemotaxis of both eosinophils and basophils. This creates a self-reinforcing inflammatory loop at the site of exposure.

Bottom line

Elevated eosinophils and basophils are robust clinical biomarkers of active type 2 (Th2) allergic inflammation. This pathway is initiated by ongoing allergen/irritant exposure and is actively sustained by histamine-mediated H4 receptor signaling, which drives the recruitment, tissue infiltration, and activation of these key effector cells.